MARKET FOCUS
U.S. stocks ended lower on Friday, as concern over cardio-vascular risk associated with Pfizer’s pain-killer Celebrex weighed on the drug sector.
The IT sector had some bearish news in store as well, with maker of handheld devices PalmOne issuing a profit warning, while network product maker 3Com after reporting smaller-than-expected sales.
The market is also running out of steam after getting a boost from a slew of merger announcements, including Sprint’s planned acquisition of Nextel Communications in a $36-billion deal, Oracle’s $10.3-billion takeover of PeopleSoft and Symantec’s $13.5-billion purchase of Veritas Software.
OUTLOOK
With the “quadruple witching” expiration of options and futures contracts, the market is headed for quieter trading, with the markets closed on Friday for the Christmas holiday.
THE NUMBERS
The Dow Jones Industrial Average gave up 55 points, or 0.5 percent, to 10,649. The Nasdaq Composite index lost 10 points, or 0.5 percent, to 2,135 while the Nasdaq-100 index of large capitalization tech and biotech stocks ended off 0.6 percent at 1,596.
|